In two recent collaborative studies, Dr. Tracy Klein from the Washington State University College of Nursing joined a research team to delve into the evolving landscape of transparency and its impact on Advanced Practice Registered Nurses (APRNs). The studies explored the implications of industry payments and the expansion of the Open Payments database to include APRNs, a crucial shift aimed at enhancing transparency in health care.
The first publication, titled I Never Thought of it as Payment, investigated APRNs’ perceptions of the Open Payments database through qualitative workshops. With expanded prescriptive authority and increased interactions with pharmaceutical and medical device companies, APRNs are now subject to public reporting of payments such as sponsored meals, consulting fees, and educational support.
Key findings include:
- New Perspectives on Industry Interactions: APRNs were often surprised to see routine activities like sponsored meals reported as “payments,” prompting ethical reflection. Many participants had not previously considered these interactions as financial transactions influencing their professional behavior.
- Value of Transparency: While participants valued the transparency introduced by Open Payments as a tool to identify potential conflicts of interest, they expressed concerns about the unintended impact on public trust. APRNs worried that the visibility of these payments might undermine the public’s perception of their integrity and impartiality.
- Call for Education and Ethical Guidelines: The study highlighted a gap in educational preparation for APRNs on managing industry interactions ethically. Participants suggested integrating ethical considerations into training programs to better equip APRNs in navigating these complex relationships.
The research emphasizes the importance of awareness as a precursor to action, suggesting that Open Payments can serve as a catalyst for broader conversations about ethics, integrity in decision-making, and the need for policy advocacy in nursing practice.
The second study, An Overview of Open Payments: Public Reporting of Pharmaceutical and Medical Device Industry Payments to APRNs, provides a comprehensive analysis of the recent policy changes expanding Open Payments to include APRNs. This study aimed to familiarize APRNs with the database and assess the implications for practice patterns.
Key highlights include:
- Legislative Expansion: As of July 2021, pharmaceutical and medical device companies must report all payments to APRNs, including meals, consulting fees, and gifts. This expansion aims to increase transparency and accountability in the interactions between APRNs and industry.
- Analysis of Payment Data: In 2022, 36% of nurse practitioners reported receiving at least one industry payment, primarily for food and beverages. The median value of these payments was modest yet concerns about the influence of even low-value payments on prescribing patterns persist.
- Opportunities for Policy Development: The inclusion of APRNs in Open Payments opens a window for the profession to shape policies and address potential conflicts of interest. The data may prompt APRNs to critically evaluate their industry relationships and advocate for more independent sources of clinical information.
Implications for Nursing Practice
Together, these studies underscore a pivotal moment for the nursing profession. The expansion of Open Payments introduces both challenges and opportunities for APRNs:
- Enhancing Ethical Awareness: APRNs need to be aware of the potential bias introduced by industry payments and consider how transparency may affect public trust. The studies suggest a need for ongoing professional education focused on ethical decision-making and integrity.
- Navigating Public Perception: As the most trusted profession, APRNs face unique risks when industry payments are publicly disclosed. Maintaining trustworthiness will require deliberate efforts to ensure that clinical decisions are guided by patient interests rather than industry influence.
- Shaping Health Policy: The Open Payments data provides an evidence-based platform for APRNs to engage in policy discussions about the ethical dimensions of industry interactions. By leading these conversations, APRNs can help develop guidelines that promote transparency while safeguarding the autonomy and trust essential to patient care.
Dr. Tracy Klein’s involvement in these studies highlights the WSU College of Nursing’s commitment to advancing knowledge and ethical practice in health care. As transparency in industry relationships becomes a critical focus, APRNs have a unique opportunity to reflect on their practices, advocate for ethical guidelines, and contribute to policy development that prioritizes patient care and professional integrity. These efforts align with the broader goal of fostering a health care environment that is both transparent and trustworthy.
References
Grundy, Q., Rudner, N., Klein, T., Ladd, E., Hart, D., MacIsaac, M., & Bero, L. (2024). “I never thought of it as payment”: Qualitative evaluation of workshops with advanced practice registered nurses on pharmaceutical industry payment reporting. Journal of the American Association of Nurse Practitioners, 10.1097/JXX.0000000000001077. Read the article here.
MacIsaac, M., Rudner, N., Klein, T., Ladd, E., Hart, D., Baugh, C. M., & Grundy, Q. (2024). An Overview of Open Payments: Public Reporting of Pharmaceutical and Medical Device Industry Payments to Advanced Practice Registered Nurses. The Journal for Nurse Practitioners, 20(10), 105134. Read the article here.
